ID: ALA3605832
Chembl Id: CHEMBL3605832
PubChem CID: 89939272
Max Phase: Preclinical
Molecular Formula: C26H27FN2O3S
Molecular Weight: 466.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)c1ccc(CC(=O)N2Cc3ccc(S(=O)(=O)Nc4ccc(F)cc4)cc3C2)cc1
Standard InChI: InChI=1S/C26H27FN2O3S/c1-26(2,3)21-7-4-18(5-8-21)14-25(30)29-16-19-6-13-24(15-20(19)17-29)33(31,32)28-23-11-9-22(27)10-12-23/h4-13,15,28H,14,16-17H2,1-3H3
Standard InChI Key: MZYILFOKCRYYRO-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 466.58 | Molecular Weight (Monoisotopic): 466.1726 | AlogP: 5.01 | #Rotatable Bonds: 5 |
| Polar Surface Area: 66.48 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 7.92 | CX Basic pKa: ┄ | CX LogP: 4.90 | CX LogD: 4.80 |
| Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.57 | Np Likeness Score: -1.75 |
| 1. Busujima T, Tanaka H, Shirasaki Y, Munetomo E, Saito M, Kitano K, Minagawa T, Yoshida K, Osaki N, Sato N.. (2015) Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor., 23 (17): [PMID:26210160] [10.1016/j.bmc.2015.06.065] |
Source(1):
